A study of the drug tildrakizumab for plaque psoriasis
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Dermatology"
DOI: 10.1111/bjd.19075
Abstract: Tildrakizumab is a fairly new type of medicine called a biologic, used for the treatment of moderate‐to‐severe psoriasis. The drug prevents the action of a specific molecule in the body involved in inflammation, known as… read more here.
Keywords: drug tildrakizumab; drug; study drug; tildrakizumab plaque ... See more keywords